Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes

被引:4
|
作者
Zhang, Chaoting [1 ]
Sun, Yizhe [1 ]
Li, Shance [1 ]
Shen, Luyan [1 ]
Teng, Xia [1 ]
Xiao, Yefei [1 ]
Wu, Nan [2 ]
Lu, Zheming [1 ]
机构
[1] Peking Univ, Lab Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing,Canc Hosp & Inst, Beijing, Peoples R China
[2] Peking Univ, Dept Thorac Surg 2, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing, Peoples R China
关键词
Immunotherapy; Adoptive; T-Lymphocytes; CELLS; ACTIVATION; CANCER;
D O I
10.1136/jitc-2022-004868
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Although adoptive cell therapy with tumor infiltrating lymphocytes (TILs) has mediated effective antitumor responses in several cancers, dysfunction and exhaustion of TILs significantly impair the therapeutic effect of TILs. Thus, it is essential to elucidate the exhausted characteristics of TILs and improve the antitumor effect of TILs by reversing their exhaustion. Here, we focused on the influence of autophagy on TILs in terms of T-cell activation, proliferation, and differentiation in vitro and in vivo. Methods We first evaluated autophagy level of TILs and influence of spermidine treatment on autophagy levels of TILs. Furthermore, we assessed the proliferative potential, phenotypical characteristics, T cell receptor (TCR) repertoire and antitumor activity of TILs with and without spermidine treatment. Results We found that autophagic flux of TILs, especially exhausted TILs that express inhibitory immunoreceptors and have impaired proliferative capacity and decreased production of cytotoxic effector molecules, was significantly impaired. The restoration of autophagic flux via spermidine treatment resulted in increased diversity of the TCR repertoire, reduced expression of inhibitory immunoreceptors (PD1, TIM3, or LAG3), enhanced proliferation and effector functions, which subsequently demonstrated the superior in vitro and in vivo antitumor activity of TILs. Our findings unveil that spermidine, as an autophagy inducer, reverses dysfunction and exhaustion of TILs and subsequently improves the antitumor activity of TILs. Conclusions These data suggest that spermidine treatment presents an opportunity to improve adoptive TIL therapy for the treatment of solid tumors.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade
    Alexander, Eric T.
    Mariner, Kelsey
    Donnelly, Julia
    Phanstiel, Otto
    Gilmour, Susan K.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2012 - 2022
  • [42] COSTIMULATORY ANTIGEN RECEPTOR (COSTAR): A NOVEL PLATFORM THAT ENHANCES THE ACTIVITY OF TUMOR INFILTRATING LYMPHOCYTES (TILS)
    Sukumaran, Sujita
    Kalaitsidou, Milena
    Mojadidi, Michelle
    Yarka, Clare
    Ouyang, Yong
    Gschweng, Eric
    Kueberuwa, Gray
    Bridgeman, John
    Hawkins, Bob
    Alvarez-Rodriguez, Ruben
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A209 - A209
  • [43] Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitro
    Burger, UL
    Chang, MP
    Nagoshi, M
    Goedegebuure, PS
    Eberlein, TJ
    ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (06) : 580 - 587
  • [44] ROLE OF TUMOR INFILTRATING LYMPHOCYTES IN TUMOR SPECIFIC CYTOTOXICITY
    VERMA, BK
    MYERS, WL
    FASEB JOURNAL, 1991, 5 (04): : A638 - A638
  • [45] Efficacy of treatment with tumor-infiltrating lymphocytes as adoptive cell therapy: an integrative review
    da Silva, Lucas Marques Soares
    Gomes, Eleni Solange de Brito
    Vieira, Julia Hailer
    de Aguiar, Murilo Porfirio
    da Silva, Saulo Fernando Moreira
    Michelin, Marcia Antoniazi
    EINSTEIN-SAO PAULO, 2024, 22
  • [46] Efficacy and safety of autologous expanded tumor infiltrating lymphocytes (TILs) in multiple solid tumors
    Amaria, Rodabe Navroze
    Vining, David J.
    Kopetz, Scott
    Overman, Michael J.
    Javle, Milind M.
    Antonoff, Mara
    Tzeng, Ching-Wei D.
    Wolff, Robert A.
    Pant, Shubham
    Lito, Kathryn
    Rangel, Kelly M.
    Wilson, Louis
    Fellman, Bryan M.
    Haymaker, Cara L.
    Yuan, Ying
    Forget, Marie-Andree
    Hwu, Patrick
    Bernatchez, Chantale
    Jazaeri, Amir A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] ANTITUMOR ANTIBODY PRODUCED BY HUMAN TUMOR-INFILTRATING AND PERIPHERAL-BLOOD B-LYMPHOCYTES
    PUNT, CJA
    BARBUTO, JAM
    ZHANG, H
    GRIMES, WJ
    HATCH, KD
    HERSH, EM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 38 (04) : 225 - 232
  • [48] INVIVO ANTITUMOR-ACTIVITY OF TUMOR-INFILTRATING LYMPHOCYTES EXPANDED IN RECOMBINANT INTERLEUKIN-2
    SPIESS, PJ
    YANG, JC
    ROSENBERG, SA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1987, 79 (05): : 1067 - 1075
  • [49] Rescue of Tumor-Infiltrating Lymphocytes from Activation-Induced Cell Death Enhances the Antitumor CTL Response in CD5-Deficient Mice
    Tabbekh, Mouna
    Franciszkiewicz, Katarzyna
    Haouas, Houda
    Lecluse, Yann
    Benihoud, Karim
    Raman, Chander
    Mami-Chouaib, Fathia
    JOURNAL OF IMMUNOLOGY, 2011, 187 (01): : 102 - 109
  • [50] Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor
    vanBree, C
    Krooshoop, JJ
    Rietbroek, RC
    Kipp, JBA
    Bakker, PJM
    CANCER RESEARCH, 1996, 56 (03) : 563 - 568